Kura Oncology (KURA) Announces Clinical Hold on Phase 1b Study of KO-539

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. HOOD
10. RGNX

Go back to Kura Oncology (KURA) Announces Clinical Hold on Phase 1b Study of KO-539
(NASDAQ: KURA) Delayed: 10.37 +0.44 (4.43%)
Previous Close $9.93    52 Week High $8.90 
Open $9.96    52 Week Low $2.50 
Day High $10.54    P/E N/A 
Day Low $9.95    EPS $0.00 
Volume 1,111,923